Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

TCR-enriched clone type as well as acquisition method and application thereof

An acquisition method and clonotype technology, applied in the field of TCR enrichment clonotype and its acquisition

Inactive Publication Date: 2021-08-06
HUNAN YUANPIN CELL TECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most of them use the same method as SARS in the past for symptomatic treatment, using hormones to suppress the inflammatory response triggered by the immune system, but at the same time, it will also make people feel very fragile and will inevitably be damaged

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • TCR-enriched clone type as well as acquisition method and application thereof
  • TCR-enriched clone type as well as acquisition method and application thereof
  • TCR-enriched clone type as well as acquisition method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the present invention will be further described in detail below in conjunction with the accompanying drawings.

[0021] The present invention provides a TCR enriched clonotype, the amino acid sequence of the TCR enriched clonotype is: CAVNSYNTDKLIF_CATSREEDNTYEQYF.

[0022] Wherein, the TCR-enriched clonotype is enriched in cell clusters of effector CD4+T memory cells.

[0023] Such as figure 1 As shown, the present invention also provides a method for obtaining the above-mentioned TCR-enriched clonotype, comprising the following steps:

[0024] S1. Collection of peripheral blood mononuclear cell samples from cured patients with viral infection;

[0025] S2. Perform TCR / BCR V(D)J immune repertoire sequencing analysis on the collected samples to find the common CDR3 variable region;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biological medicine, and particularly discloses a TCR-enriched clone as well as an acquisition method and application thereof. The TCR-enriched clone has an amino acid sequence of CAVNSYNTDKLIF_CATSREEDNTYEQYF, can provide specifically recognized epitopes for vaccine development, and can be used for guiding vaccine development and providing direction and theoretical basis for vaccine development and research.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a TCR-enriched clonotype and its acquisition method and application. Background technique [0002] The outbreak of novel coronavirus (2019-novel coronavirus, 2019-nCoV) infection poses a serious threat to global public health. The disease caused by 2019-nCoV was officially named COVID-19 (coronavirus disease 2019) by the World Health Organization (WHO). COVID-19 is clinically manifested as pneumonia, fever, cough, muscle pain, fatigue, diarrhea and, in severe cases, death. The WHO report shows that 2019-nCoV has caused a worldwide pandemic. Vaccination is an effective means to prevent the spread of viral infection, but there is currently no new coronavirus vaccine (hereinafter referred to as the new crown vaccine). For the rapid spread of the COVID-19 virus in the public, the current treatment is still based on supportive care. Antiviral drugs, antibodies, and vaccines aga...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/725C12N5/0783
CPCC07K14/7051C12N5/0636C12N2509/00
Inventor 李婵艺薛志刚薛金锋伊宁齐凌彬吕波李伟林
Owner HUNAN YUANPIN CELL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products